Hot Spot TrackingWorth Watching

Trump's $2B Quantum Grant Lands, QBTS/RGTI/IBM Surge Together

Event Interpretation

The U.S. Department of Commerce officially announced the grant of approximately $1B in CHIPS Act subsidies to IBM, simultaneously unveiling a $2B quantum chip manufacturing base plan; this is real capital deployment rather than a letter of intent.

The Trump administration plans to swap $2B directly for equity in quantum companies. Government equity stakes in tech firms are rare and the market views this as a national-level endorsement.

QBTS won a standalone $1B federal contract on the same day and held its first investor day; the resonance of these three catalysts triggered a massive inflow of capital into the entire quantum sector.

Related Targets

QBTS

$17.87

D-Wave Quantum-0,06%

$6.432,71 M

24h Volume

$13,5 M

AI AnalysisHighest gain of 33.3% and secured a $1 billion federal contract on the same day; dual catalyst resonance, most media coverage.

RGTI

$16.31

Rigetti-0,03%

$5.298,43 M

24h Volume

$240,32 M

AI AnalysisQuantum processor developer at the core of quantum hardware; named as a beneficiary of the $2B government investment, sector linkage amplified the gain; no stable revenue, purely policy-driven, high volatility.

IBM

$231.11

IBM-0,01%

$216,56 mil M

24h Volume

$1.059,82 M

AI AnalysisTraditional IT giant and quantum chip manufacturer; $1B subsidy injected directly into quantum manufacturing business, Anderson base plan is highly certain; large cap, small share of quantum business, lower elasticity than pure-play quantum stocks.

INTC

$89.93

Intel+0,02%

$445,08 mil M

24h Volume

$6.357,19 M

AI AnalysisAnother beneficiary of the CHIPS Act, possesses quantum chip R&D capabilities; if the government continues to support quantum manufacturing with CHIPS Act funds, Intel's quantum division could receive similar subsidies; core PC chip business is under pressure, quantum business contribution is extremely low.

The above content is AI-generated for reference only.